DexCom Outlines Growth Plan for G8 Launch, Coverage Expansion
DexCom outlined a long-term growth strategy targeting over 10% annual revenue growth through 2030 during its Investor Day. The company plans to launch the next-generation G8 glucose monitor around late 2027 or early 2028 and aims for broader insurance coverage, particularly among type 2 diabetes patients not using insulin.
Tickers: $DXCM
Topics: coverage_expansion product_launch revenue_growth stock_repurchase